Carmell announces pipe investment from existing and new investors to support commercial build-out

Pittsburgh, dec. 24, 2024 (globe newswire) -- carmell corporation (nasdaq: ctcx), a bio-aesthetics company focused on skin and hair health (“carmell”, the “company”, “we”, “our”, or “us”), today announced that it entered into a securities purchase agreement with new and existing investors for the issuance and sale of 8,065,210 shares of its common stock and an equal number of five-year warrants, both priced at $0.23 per share, in a private placement for aggregate gross proceeds of $1.85 million before deducting offering expenses and fees (the “private placement”). the warrants, if exercised, will result in an additional $1.85 million in proceeds to carmell.
XAGE Ratings Summary
XAGE Quant Ranking